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Abstract
Background: Pneumonia is a primary cause of morbidity and mortality in infectious disease, and increasing
antimicrobial resistance has raised concerns of treatment failure. Therefore, we evaluated the value of a blood
culture bottle for bronchoalveolar lavage (BAL) samples on pathogen identification and on treatment modification in
patients with pneumonia.
Methods: We conducted a prospective study and enrolled 39 patients who were hospitalized for pneumonia. Enrolled
patients underwent BAL; a 10-ml aliquot was transferred to a sterile container for standard quantitative culture, and a
5 ml aliquot was transferred to both an aerobic and an anaerobic blood culture bottle.
Results: Microbes were detected in all 39 (100 %) specimens and possible pathogens were identified in 34
patients (84.6 %) from BAL blood culture bottles. In contrast, microbes were detected in 10 patients (25.6 %)
and possible pathogens were isolated in 8 patients (20.5 %) in BAL fluid using conventional culture methods.
Finally, 8 of 39 (20.5 %) patients changed antibiotics according to the BAL blood culture results and pneumonia
improved in 6 of these patients.
Conclusions: Using blood culture bottles for BAL sampling in patients with pneumonia is a sensitive method to detect
pathogens in order to identify an adequate antibiotic treatment regimen.
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Background
Pneumonia is a major cause of morbidity and mortality
in infectious disease [1]. Quick and effective antibiotic
administration is key for successful treatment of pneu-
monia [2], however increasing antimicrobial resistance
has raised concerns regarding the failure of pneumonia
treatment. Risk and fear of resistant organisms cause
physicians to overuse broad-spectrum antibiotics,
possibly worsening the selection and multiplication of
drug-resistant organisms. If we can isolate the causative
pathogens and identify their antibiogram, particularly
in hospital-acquired pneumonia (HAP)/ventilator-asso-
ciated pneumonia (VAP), which is a high-risk factor for
drug-resistant pathogens, physicians could more easily
select adequate antibiotics and improve treatment
success rates.
In order to diagnose an infection in sterile fluid such
as ascites, pleural effusion, or joint fluid, use of a blood
culture bottle is more sensitive than conventional cul-
ture methods to isolate pathogens [3–6]. The standard
method of body fluid culture uses a solid media for cul-
ture, and before inoculating bacteria, the specimen is
transferred to the laboratory and requires various proce-
dures, such as filtration and centrifugation, to concen-
trate the organism. In addition, only a small amount of
the specimen is inoculated on the medium lowering the
probability of isolating the microorganism [7, 8]. Blood
culture bottles contain enriched growth media as well as
specific media to remove antibiotics, allowing for growth
of microorganisms [9]. Also, inoculating body fluid spec-
imens immediately into the medium in blood culture
bottle can improve survival of the microbes.
However, unsterile body fluid, such as that from the
bronchial tree, is considered unacceptable material to in-
oculate into blood culture bottles due to the inevitable
bacterial contamination. There is no study evaluating
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the utility of blood culture bottles to improve the
diagnostic and therapeutic significance of bronchoal-
veolar lavage (BAL) fluid in pneumonia. Therefore,
we conducted a single-center pilot study to evaluate
the effect of using a blood culture bottle with BAL
fluid for pathogen identification and for treatment
modification in patients with pneumonia.
Methods
Study subjects and design
We conducted a prospective study at Boramae Medical
Center. We enrolled 39 patients who were hospitalized for
pneumonia and agreed to a bronchoscopy. Pneumonia
was clinically defined as the presence of a new, persistent,
or progressive infiltration by chest radiograph as well as at
least two of the following criteria: 1) temperature >38 °C
or <35 °C; 2) leukocytosis count >10,000/mm3 or <3,000/
mm3; or 3) purulent secretions. The definitions of HAP,
VAP, and health care-associated pneumonia (HCAP) are
summarized in Table 1.
Sputum culture method
Sputum specimens were usually collected before anti-
biotic therapy was begun. The sputum collection and
microbiologic evaluation were performed according to
the institution’s procedure manual and a reference [10].
The patients were instructed not to expectorate saliva or
postnasal discharge into the container, and were edu-
cated as how to collect expectorated sputum specimens
into a sterile container. The collected sputum specimens
were transferred to the microbiology laboratory for an
initial Gram stain for quality evaluation based on micro-
scopic criteria. The Gram staining results were then
used to grade the specimen with the Murray and
Washington’s system [11–13]. Sputum samples of grade
4 or 5 were considered acceptable and processed for
further microbiological studies. Sputum cultures were
processed immediately on blood agar, chocolate agar,
and MacConkey agar plate.
Bronchoscopy and culture method
A bronchoscopy and BAL were performed on enrolled
patients. We performed BAL with serial 50 ml fractions
of 0.9 % NaCl to a total volume of 100–150 ml using a
flexible bronchoscope (Olympus MH-553, Tokyo, Japan).
A 10 ml aliquot was transferred to a sterile container for
standard Gram staining and quantitative culture. Pairs of
aerobic and anaerobic blood culture bottles (BacT/Alert
3D System, Becton Dickinson, Sparks, Maryland, USA)
were inoculated with 5 ml of retrieved BAL fluid for cul-
ture. For quantitative culture, 100 μL of BAL fluid was
inoculated onto a blood agar plate, a MacConkey agar
plate, a chocolate agar plate, and a Brucella blood agar
plate (HANIL KOMED CO., Gyeonggi-do, Korea). Blood
and MacConkey agar plates were incubated aerobically
in 5 % CO2 at 35 °C for 18–24 h. Chocolate and Brucella
blood agar plates were anaerobically incubated for up to
48 h. For the qualitative culture, 100 μl of vortexed BAL
specimen was transferred to the plate; each colony from
this plate was 10 colony-forming units (CFU)/ml. A col-
ony number of more than 104 CFU/ml was considered
significant for a pathogen. The sediment after centrifu-
gation of the remaining BAL fluid was used for a smear
preparation for Gram staining.
The blood culture bottles containing BAL fluid were in-
cubated in the BacT/Alert 3D System (Becton Dickinson)
at 35 °C for up to 5 days. A Gram stain was performed on
any positive bottles and subcultures were performed on
an appropriate solid media to identify the organism and
perform antibiotic susceptibility testing using a disc
diffusion test.
Analysis
The results of pathogen isolation were compared between
BAL conventional culture and blood culture using BAL
fluid. If one or more possible pathogenic organisms were
detected from the BAL fluid in blood culture, we consid-
ered more likely pathogenic bacteria as the causative or-
ganisms. If two or more types of well-known pathogenic
bacteria were isolated from the same specimen, all of them
were considered pathogens of pneumonia. Gram-positive
cocci without further differentiation, Gram-negative rods
without differentiation, and Candida albicans were classi-
fied as colonizers or contamination.
This study was approved by the Institutional Review
Board of Boramae Medical Center (IRB no. 06–2012–21),




Bronchoscopy and BAL was performed on a total of 39
patients with pneumonia during the study period. The
median age of the patients was 70.5 years and 69.2 %
Table 1 Definitions of HAP, VAP, and HCAP (7)
• HAP (hospital-acquired pneumonia)
Pneumonia that occurs ≥48 h from time of admission
• VAP (ventilator-associated pneumonia)
Pneumonia that arises 48 to 72 h after endotracheal intubation
• HCAP (healthcare-associated pneumonia)
Prior hospitalization ≥2 days (within 90 days)
Resided in nursing home or long-term care facility
Received recent IV antibiotics, chemotherapy, or wound care
(within 30 days)
Attended a hospital or hemodialysis clinic
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were male. Half of the patients (53.8 %) had community-
acquired pneumonia (CAP). All except one had been
treated with antibiotics before the bronchoscopy. The
mean duration of the administration of antibiotics before
bronchoscopy was 5.8 days (Table 2).
Comparison of culture positivity and concordance rate of
isolated pathogens from BAL fluid between the
conventional method and the blood culture bottle
Microbes were detected from all 39 (100 %) speci-
mens using blood culture bottles. A single organism
was isolated in 22 patients (56.4), 2 in 14 patients
(35.9), and 3 or more in 3 patients (7.7 %). Except
for five cases with colonizers that were unidentified
Gram-positive cocci, Delftia acidovorans, Pseudomonas
putida, and two C. albicans, possible pathogens were iden-
tified in 34 patients (84.6 %) from BAL blood culture. How-
ever, in BAL fluid conventional culture, no organisms or
normal throat flora were grown in 29 patients (74.4 %), and
a single microbe was detected by BAL fluid conventional
culture in 10 patients (25.6 %). Except for two C. albicans
cases, organisms that reached the qualifying > 104 CFU/ml
threshold were detected in 4 patients (10.3 %) among 8
patients (20.5 %), in whom possible pathogens were isolated
using conventional BAL quantitative culture.
No organisms were isolated from BAL standard cul-
ture compared with BAL blood culture, in which the
growth of methicillin-resistant Staphylococcus aureus
(MRSA) and Klebsiella pneumonia were reported in the
only patient who did not receive antibiotics before
bronchoscopy. Frequency and types of isolated micro-
organisms are summarized in Table 3.
The results of pathogen isolation were consistent be-
tween BAL conventional culture and blood culture in 7
out of 10 patients who had positive results from BAL
conventional culture. Among 3 patients who had dis-
cordant culture results, 2 had changed antibiotics follow-
ing the BAL fluid blood culture results. In the remaining
patient, MRSA through BAL conventional culture and
extended spectrum beta-lactamase (ESBL) K. pneumo-
niae were isolated from BAL blood culture. The patient
continued treatment with piperacillin and tazobactam
with levofloxacin and the pneumonia improved. Among
7 patients who had concordant culture results, 5 chan-
ged antibiotics according to the BAL fluid culture results
(1 ESBL Escherichia coli, 1 Stenotrophomonas maltophilia,
and 3 imipenem-resistant Acinetobacter baumannii
(IRAB)). The remaining 2 patients (1 C. albicans and 1
MRSA) continued with their antibiotics and improved.
Impact of relying on blood culture bottle results for
treatment modification
Finally, 8 of 39 (20.5 %) patients changed their antibi-
otics according to the BAL blood culture results, and
pneumonia was improved in 6 patients (Table 4).
Half of the patients who changed antibiotics had
CAP. In CAP, pathogens which were resistant to
beta-lactam antibiotics were the main cause of de-
layed treatment response. In one CAP case, MRSA
was isolated and pneumonia improved after adding
vancomycin to the treatment regimen. In two cases of
HCAP/HAP, IRABs were detected in BAL blood culture
bottle samples and colistin was added to the patients’
treatment. In a 75-year-old male patient with HAP, culture
results were discordant; conventional BAL fluid culture
detected methicillin-resistant coagulase-negative staphylo-
cocci (MRCNS) whereas Pseudomonas aeruginosa was
isolated in the BAL blood culture bottle. The physician ad-
justed the patient’s antibiotics to be more suitable for P.
aeruginosa, which is generally more pathogenic than
MRCNS, and the patient responded favorably.
Two patients died after changing antibiotics according
to the BAL result from the blood culture bottle during
the admission period. One 88-year-old patient had S.
maltophilia, which was resistant to carbapenem, but
sensitive to aminoglycoside, ciprofloxacin, and Bactrim,
isolated in BAL fluid by conventional culture and all
Table 2 Baseline characteristics of patients (N = 39)
Variables N (%)
Age (years)





HAP & VAP 12 (30.8)
Comorbidities
Diabetes mellitus 5 (12.5)
Solid organ malignancy 11 (27.5)
Hematologic malignancy 2 (5)
Chronic respiratory disease 8 (20.5)
HIV infection 1 (2.6)
Antibiotics started on admission 38 (97.4)
Antibiotics started within 24 h before BAL 13 (33.3)
Duration of antibiotics before bronchoscopy
(days), mean ± SD
5.8 ± 6.4
Leukocytes (per mm3), mean ± SD 11,226 ± 5056
C-reactive protein (mg/dL), mean ± SD 11.74 ± 8.24
Pneumonia outcome
Improved 31 (77.5)
Transferred out 1 (2.5)
Died 7 (17.5)
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sensitive P. aeruginosa isolated in BAL fluid blood cul-
ture. Therefore, the patient’s antibiotics were stepped
down from meropenem to ceftazidime and ciprofloxacin.
At first, the patient improved and was moved from the
intensive care unit (ICU) to the general ward. However,
he could not expectorate sputum effectively and his
pneumonia deteriorated again. The patient’s family
rejected further invasive management and the patient
died. Following his death, IRAB was isolated from the
last sputum culture. The second patient had been
treated for non-small cell lung cancer and died abruptly
due to asphyxia. The patient’s pneumonia had been im-
proving after changing antibiotics according to the BAL
fluid culture result.
When a strategy of based on a BAL standard culture
criteria with a 104 CFU/ml threshold was employed, em-
pirical antibiotic treatments were adequate in 25 out of
31 patients in whom BAL culture results were no growth
or throat normal flora including C. albicans. However, 5
patients died in spite of adequate antibiotic therapy,
whereas in 6 out of 31 patients, pneumonia was im-
proved after adjusting antibiotics according to BAL
blood culture results.
BAL standard culture results were concordant with
BAL blood culture results in 3 out of 4 cases, in whom
an organism was reported but did not meet the
104 CFU/ml threshold in BAL standard culture; all pa-
tients changed antibiotic treatment guided by culture re-
sults. One other case (Case 1 in Table 4) with discordant
results changed treatment according to the BAL blood
culture results and his pneumonia improved. Among 4
patients with a number of organisms that surpassed the
104 CFU/ml threshold in BAL standard culture, one pa-
tient (Case 2) changed antibiotic treatment guided by
the BAL blood culture results as shown in Table 4. In
the other 3 cases, initial antibiotics were inadequate and
changed according to the BAL standard culture results,
which were concordant with BAL blood culture results.
Table 3 Concordance between sputum culture, BAL quantitative culture, and BAL culture using blood culture bottles
Sputum culture BAL quantitative culture BAL blood bottle culture
Pseudomonas aeruginosa 4 (1: ESBL)
Klebsiella pneumoniae 1 5 (2: ESBL)
Staphylococcus aureus 5 (3: MRSA) 2 (2: MRSA) 9 (7:MRSA)
Viridans streptococci 9 (1: penicillin and other beta-lactam resistant)
Streptococcus pneumoniae 1 1 (1: penicillin and other beta-lactam resistant)
Acinetobacter baumannii 2 (2: IRAB) 2 (2: IRAB) 7 (6: IRAB)
Escherichia coli 1 2 (2: ESBL)
Stenotrophomonas maltophilia 2 1
Others MRCNS, 2 Candida albicans 2 Candida albicans, Group D Non-enterococcus,
Pseudomonas putida, Delftia acidovorans
ESBL extended spectrum beta-lactamase, IRAB imipenem-resistant Acinetobacter baumannii, MRSA methicillin-resistant Staphylococcus aureus, MRCNS methicillin-
resistant coagulase negative staphylococci





BAL fluid blood culture bottle Antibiotics before BAL Antibiotics after BAL Outcome
1 HAP MRCNS Pseudomonas aeruginosa ceftazidime, vancomycin cefepime + amikacin improved
2 CAP Stenotrophomonas
maltophilia
P. aeruginosa meropenem ceftazidime, ciprofloxacin death
3 HAP throat normal flora Enterococcus faecium, IRAB meropenem colistin death
4 CAP none MRSA, Klebsiella pneumoniae ampicillin/sulbactam ampicillin, sulbactam,
vancomycin
improved
5 CAP none Viridans streptococci
(penicillin: I, clindamycin: R)
ceftriaxone, clindamycin vancomycin improved
6 HCAP none Viridans streptococci
(penicillin: R), MRCNS
ceftriaxone, azithromycin tazocin, levofloxacin improved
7 HCAP none K. pneumonia (ESBL), IRAB piperacillin + tazobactam,
meropenem
colistin improved
8 CAP none S. pneumonia (penicillin,
beta lactam: R)
ceftriaxone levofloxacin improved
ESBL extended spectrum beta-lactamase, IRAB imipenem-resistant Acinetobacter baumannii, MRSA methicillin-resistant Staphylococcus aureus, MRCNS methicillin-
resistant coagulase negative staphylococci
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Discussion
Using blood culture bottles, microorganisms were de-
tected in all 39 patients even while being treated with
antibiotics, and in 8 of these patients (20.5 %), the anti-
biotics were changed according to the results of the BAL
fluid blood culture bottle. Though two patients died dur-
ing the admission period, the change in antibiotic treat-
ment was effective in all 8 patients.
Patients with HAP/VAP tend to undergo antibiotic
treatment for a variety of reasons before the develop-
ment of pneumonia. Therefore, pathogen isolation yield
is generally low in patients with a high risk of harboring
a drug-resistant pathogen [14, 15]. Kim et al. showed
that the yield of quantitative BAL fluid culture was less
than 3 % in patients who were already on antibiotics
[14]. Patients with HAP or VAP, who have a high risk of
multidrug-resistant pathogens, are usually being treated
with antibiotics during admission, so there is less of a
chance that the organism will be identified through BAL
fluid quantitative culture. Therefore, using blood culture
bottles can be helpful in identifying organisms present in
the bronchial tree, even if they are colonizers. Routine
surveillance endotracheal aspirate cultures make it pos-
sible to prescribe adequate antibiotic therapy in 95 % of
patients in whom a VAP is ultimately diagnosed by BAL
culture [16]. In addition, a randomized trial showed that
endotracheal aspiration with non-quantitative culture of
the aspirate to diagnose VAP is associated with clinical
outcomes and antibiotic use similar to those associated
with BAL and quantitative culture of the BAL fluid [17].
Moreover, oropharyngeal commensals may be the causa-
tive pathogens in pneumonia [18, 19].
Early, appropriate, broad-spectrum antibiotic therapy is
recommended for successful HAP or VAP treatment [20].
However, this strategy carries with it the risk of selecting
for drug-resistant strains. Increasing multidrug-resistant
organisms are a major concern worldwide, but particularly
in Asia. Chung et al. reported that the rate of multidrug-
resistant (MDR) Acinetobacter spp. and P. aeruginosa,
which were isolated in HAP and VAP, were 82 and 42.8 %
respectively, in 10 Asian countries including Korea [21]. If
we can identify the causative pathogen of a patient’s pneu-
monia, we can not only determine the presence of a drug-
resistant pathogen and improve treatment outcome, but
also provide information for de-escalating antibiotics in
the case of drug-sensitive organisms. Adjusting antibiotics
according to the pathogen’s antibiogram can help reduce
the emergence of drug-resistant organisms that arise
through misuse of broad-spectrum antibiotics.
A limitation of this study is that there is no gold
standard method for isolating the exact causative patho-
gen in pneumonia. The bronchial tree is not a sterile
space and bronchoscopy with BAL is not a sterile pro-
cedure. Therefore, the microbe isolated from the BAL
fluid cannot be definitively identified as the causative
pathogen of a pneumonia, particularly from a blood cul-
ture bottle in which the isolated organism cannot be
quantified. However, a single organism was isolated in
22 of 39 patients, which was more than expected, from
BAL fluid blood culture. Moreover, in 8 patients who
were treated according to the BAL fluid blood culture
results, pneumonia improved after the antibiotic treat-
ment was adjusted.
Conclusion
In conclusion, using blood culture bottles for BAL
fluid culture in patients with pneumonia can be help-
ful in choosing adequate antibiotics even in patients
already on antibiotic therapy. As more multidrug-
resistant pathogens emerge, the importance of verify-
ing a pathogen’s antibiogram is growing. Therefore,
we need a sensitive method to isolate bacteria and
using a blood culture bottle may be one way to do so
in patients with pneumonia.
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